[{"arm_notes": "", "treatment_id": null, "treatment_name": "The study will include patients with COVID-19 interstitial pneumonia documented with positive SARS-CoV-2 RT-PCR test result. Single-center interventional randomized controlled trial. The intervention will consist of 2 stages. In the first stage; after tests completion (chest CT scan; gasometry measured with the SpO2 pulse oximeter; ECG; anthropometric indicators and laboratory tests ) and meeting the inclusion criteria; patients will be qualified by the attending physician to participate in the experiment. In the second stage; COVID-19 patients will be randomly assigned to one of two groups: 1/ In the first group NMES electrical stimulation will be conducted in 20 COVID-19 patients in addition to the standard treatment. Quality of life will be tested with the Polish version of the CAT questionnaire. Each patient will be assessed also using the The MRC dyspnoea scale. The exercise tolerance and dyspnoea will be assessed according to the Borg scale. Physical capacity will be assessed by selected ADL activities (e.g. sitting alone in bed with legs lowered; lifting both lower limbs separately at 30\u00b0 and holding them in this position until tired; standing alone by bed; getting out of bed and sitting alone in a chair while standing by the bed; walking without help).The implementation of the above interventions will depend on the clinical condition of the patient and will be ordered by the attending physician. Muscle electrostimulation (NMES) will be performed 5 times a week for 40 minutes under the supervision of a physiotherapist and will last for 3 weeks (15 sessions). NMES will be conducted on thigh muscles (20 mins) and cal", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 879, "treatment_name": "Neuromuscular electrical stimulation", "treatment_type": "Medical device", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "The study will include patients with COVID-19 interstitial pneumonia documented with positive SARS-CoV-2 RT-PCR test result. Single-center interventional randomized controlled trial.The intervention will consist of 2 stages. In the first stage; after tests completion (chest CT scan; gasometry measured with the SpO2 pulse oximeter; ECG; anthropometric indicators and laboratory tests ) and meeting the inclusion criteria; patients will be qualified by the attending physician to participate in the experiment.In the second stage; COVID-19 patients will be randomly assigned to one of two groups:1/ In the first group NMES electrical stimulation will be conducted in 20 COVID-19 patients in addition to the standard treatment. Quality of life will be tested with the Polish version of the CAT questionnaire. Each patient will be assessed also using the The MRC dyspnoea scale. The exercise tolerance and dyspnoea will be assessed according to the Borg scale.Physical capacity will be assessed by selected ADL activities (e.g. sitting alone in bed with legs lowered; lifting both lower limbs separately at 30\u00b0 and holding them in this position until tired; standing alone by bed; getting out of bed and sitting alone in a chair while standing by the bed; walking without help).The implementation of the above interventions will depend on the clinical condition of the patient and will be ordered by the attending physician.Muscle electrostimulation (NMES) will be performed 5 times a week for 40 minutes under the supervision of a physiotherapist and will last for 3 weeks (15 sessions). NMES will be conducted on thigh muscles (20 mins) and calf muscles (20 mins) of both limbs. The electrodes will be placed on the proximal and distal ends of the muscle bellies. An biphasic symmetrica", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 879, "treatment_name": "Neuromuscular electrical stimulation", "treatment_type": "Medical device", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "The study will include patients with COVID-19 interstitial pneumonia documented with positive SARS-CoV-2 RT-PCR test result. Single-center interventional randomized controlled trial. The intervention will consist of 2 stages. In the first stage; after tests completion (chest CT scan; gasometry measured with the SpO2 pulse oximeter; ECG; anthropometric indicators and laboratory tests ) and meeting the inclusion criteria; patients will be qualified by the attending physician to participate in the experiment. In the second stage; COVID-19 patients will be randomly assigned to one of two groups: 1/ In the first group NMES electrical stimulation will be conducted in 20 COVID-19 patients in addition to the standard treatment. Quality of life will be tested with the Polish version of the CAT questionnaire. Each patient will be assessed also using the The MRC dyspnoea scale. The exercise tolerance and dyspnoea will be assessed according to the Borg scale. Physical capacity will be assessed by selected ADL activities (e.g. sitting alone in bed with legs lowered; lifting both lower limbs separately at 30\u00b0 and holding them in this position until tired; standing alone by bed; getting out of bed and sitting alone in a chair while standing by the bed; walking without help).The implementation of the above interventions will depend on the clinical condition of the patient and will be ordered by the attending physician. Muscle electrostimulation (NMES) will be performed 5 times a week for 40 minutes under the supervision of a physiotherapist and will last for 3 weeks (15 sessions). NMES will be conducted on thigh muscles (20 mins) and cal", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]